Berkshire Hathaway (BRK-B) to Acquire OxyChem for $9.7 Billion

Berkshire Hathaway Inc. (NYSE:BRK-B) is one of the 10 Most Profitable Stocks of the Last 5 Years. On October 2, Berkshire Hathaway Inc. (NYSE:BRK-B) announced that it has entered a definitive agreement to acquire Occidental’s chemical business, OxyChem.

According to the report by Berkshire Hathaway Inc. (NYSE:BRK-B), this deal has an all-cash transaction value of $9.7 billion and is expected to be concluded in the fourth quarter of 2025.

Berkshire Hathaway (BRK-B) to Acquire OxyChem for $9.7 Billion

Skyscrapers with background of graphs and arrows

OxyChem manufactures essential commodity chemicals that are used in areas like water treatment, pharmaceuticals, healthcare, and both commercial and residential development.

Through this acquisition, Berkshire Hathaway Inc. (NYSE:BRK-B) will get a strong set of operating assets, which are supported by an experienced and skilled team. OxyChem will become an operating subsidiary within Berkshire Hathaway Inc. (NYSE:BRK-B)

Berkshire Hathaway Inc. (NYSE:BRK-B) is an American multinational company that is engaged in a wide range of businesses including insurance and reinsurance, utilities and energy, freight rail transportation, manufacturing, services, and retailing.

While we acknowledge the potential of BRK-B as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BRK-B and that has a 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 15 Best American Tech Stocks to Buy Right Now and 14 Small Publicly Traded Semiconductor Companies to Invest in Now.

Disclosure: None. This article is originally published at Insider Monkey.